With the results derived from these two clinical trials and considering the large number of opportunistic screenings, an updated Council of the EU recommendation on PCa screening invited countries to proceed with a stepped approach based on piloting and further research to assess the feasibility and effectiveness of the implementation of organized screening programs, ensuring quality and appropriate management based on PSA testing followed by MRI scanning [20]. Here, KLK3 is linked to posterior cortical atrophy.